is there a shortage of tirzepatide FDA confirms still over, gives compounders grace period Eli Lilly's Weight-Loss, Diabetes Drug

The findings, which have yet to be published, showed that Tirzepatide reduced participants risk of heart failure outcomes The trial followed 731 adults with heart failure with preserved ejection fraction (HFpEF) and obesity who received either tirzepatide or a placebo over the course of a year

Many patients pair injectable weight loss medications with Emsculpt NEO or other body contouring options to sculpt and tone once they've reached a healthier baseline weight

As the medication passes the shelf life, the compounds can break down, leading to changes in how the drug might react in the body

We provide weekly emails with healthy meals, exercise tips, and up-to-date information about the weight loss medications

Our dedicated healthcare professionals are ready to provide personalized guidance to determine if tirzepatide is the right therapeutic choice for your unique medical journey